NASDAQ:IOVA   Iovance Biotherapeutics, Inc.
This is 12-month outlook for IOVA from several different angles (meaning sized bars, heavy emphasis on 1-day and 2-day). Temporary weakness in volume structure has been considered and expected to resolve by January 2021. Future looks bright.
Comment:
Here is a zoom in for temporary weakness expected this late Nov 2020 to Jan 2021 window:


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.